Skip to main content
. 2023 Oct 11;18(10):e0292678. doi: 10.1371/journal.pone.0292678

Fig 3. LAT1 expression and prognosis in patients from other datasets.

Fig 3

After patients were separated into high and low LAT1 expression groups, survival was observed in patients from the (A) “TCGA TARGET GTEx”, (B) “Node–negative breast cancer (Desmedt 2007)”, (C) “ICGC (donor centric)”, (D) “Breast Cancer (Chin 2006)”, and (E) “Breast Cancer (Miller 2005)” cohorts.